I Wayan Gede Sutadarma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
I Wayan Gede Sutadarma has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Agustinus I Wayan Harimawan
Department of Clinical Nutrition, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia
3 shared publications - I Wayan Weta
Department of Clinical Nutrition, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia
3 shared publications - Ni Ketut Sumartini
Department of Clinical Nutrition, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia
3 shared publications - Syuma Adhy Awan
Department of Clinical Nutrition, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia
3 shared publications - Anak Agung Sagung Mirah Prabandari
Department of Clinical Nutrition, Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia
2 shared publications - I Wayan Surudarma
Department of Biochemistry, Faculty of Medicine, Udayana University
2 shared publications
Latest Publications
- Open Access
- 8 November 2026
- Published by Politeknik Kesehatan Kemenkes Aceh in Jurnal SAGO Gizi dan Kesehatan
- Vol. 7 (3) , 862-873
The effect of glutamine supplementation on mortality, length of hospital stay, and systemic infections in burn patients: A systematic review and meta-analysis of randomized controlled trials
Background: The clinical benefits of glutamine supplementation in patients with burn injuries remain uncertain. Although glutamine has been proposed to support immune function and recovery, its effects on major clinical outcomes are inconsistent.Objectives: This systematic review and meta-analysis evaluated the effects of glutamine supplementation on hospital length of stay, all-cause mortality, and systemic infectious complications in patients with burn injuries.Methods: PubMed/MEDLINE, Scopus, and the Cochrane Library were searched through July 26, 2026, for randomized controlled trials comparing glutamine supplementation with placebo or standard care. The review was registered in PROSPERO (CRD420261461723). Pooled estimates were calculated using random-effects models.Results: Eleven randomized controlled trials involving 1,662 participants were included. No statistically significant reductions were detected in hospital length of stay (mean difference, −3.22 days; 95% CI, −7.62 to 1.19), all-cause mortality (odds ratio, 0.92; 95% CI, 0.69–1.23), or systemic infectious complications (odds ratio, 0.97; 95% CI, 0.75–1.25). Heterogeneity was substantial for hospital length of stay (I² = 89%).Conclusions: The pooled findings did not demonstrate a clear benefit of routine glutamine supplementation for these outcomes in patients with burn injuries. Interpretation remains limited by heterogeneity and uncertainty in the included evidence.
- 8 November 2026
- Published by Politeknik Kesehatan Kemenkes Aceh in Jurnal SAGO Gizi dan Kesehatan
- Vol. 7 (3) , 862-873
Open AccessThe effect of glutamine supplementation on mortality, length of hospital stay, and systemic infections in burn patients: A systematic review and meta-analysis of randomized controlled trials
Background: The clinical benefits of glutamine supplementation in patients with burn injuries remain uncertain. Although glutamine has been proposed to support immune function and recovery, its effects on major clinical outcomes are inconsistent.Objectives: This systematic review and meta-analysis evaluated the effects of glutamine supplementation on hospital length of stay, all-cause mortality, and systemic infectious complications in patients with burn injuries.Methods: PubMed/MEDLINE, Scopus, and the Cochrane Library were searched through July 26, 2026, for randomized controlled trials comparing glutamine supplementation with placebo or standard care. The review was registered in PROSPERO (CRD420261461723). Pooled estimates were calculated using random-effects models.Results: Eleven randomized controlled trials involving 1,662 participants were included. No statistically significant reductions were detected in hospital length of stay (mean difference, −3.22 days; 95% CI, −7.62 to 1.19), all-cause mortality (odds ratio, 0.92; 95% CI, 0.69–1.23), or systemic infectious complications (odds ratio, 0.97; 95% CI, 0.75–1.25). Heterogeneity was substantial for hospital length of stay (I² = 89%).Conclusions: The pooled findings did not demonstrate a clear benefit of routine glutamine supplementation for these outcomes in patients with burn injuries. Interpretation remains limited by heterogeneity and uncertainty in the included evidence.
- Open Access
- 16 September 2026
- Published by Politeknik Kesehatan Kemenkes Aceh in AcTion: Aceh Nutrition Journal
- Vol. 11 (3) , 1003-1013
Associations of energy, protein, and zinc intake adequacy with SOFA scores and length of hospital stay in patients with major burns at Ngoerah General Hospital, Denpasar
Major burn injuries induce hypermetabolic and hypercatabolic responses that increase nutritional requirements. This retrospective cohort study aimed to evaluate the association between the adequacy of energy, protein, and zinc intake and the Sequential Organ Failure Assessment (SOFA) score and length of hospital stay in patients with major burns. Medical record data were obtained from patients treated at the Burn Unit of the Ngoerah General Hospital, Denpasar, between February 2025 and February 2026. Eligible patients were aged ≥17 years, had burns involving ≥20% of the total body surface area, received enteral nutrition, and were hospitalized for at least three days. Multivariable analyses were performed using negative binomial regression for SOFA scores and a generalized linear model with a gamma distribution and log link for the length of hospital stay. A total of 150 patients were included in the analysis. Energy, protein, and zinc adequacy were achieved by 31.3%, 41.3%, and 90.0% of the patients, respectively. None of the nutritional adequacy measures were independently associated with the length of hospital stay. Protein adequacy (adjusted IRR, 0.196; 95% CI, 0.038–0.999; P = 0.049) and zinc adequacy (adjusted IRR, 0.043; 95% CI, 0.017–0.109; P < .001) were independently associated with lower SOFA scores. In conclusion, adequate protein and zinc intakes were associated with lower SOFA scores; however, causality cannot be inferred from this retrospective study design. Prospective studies with temporally defined nutritional exposure are needed.
- 16 September 2026
- Published by Politeknik Kesehatan Kemenkes Aceh in AcTion: Aceh Nutrition Journal
- Vol. 11 (3) , 1003-1013
Open AccessAssociations of energy, protein, and zinc intake adequacy with SOFA scores and length of hospital stay in patients with major burns at Ngoerah General Hospital, Denpasar
Major burn injuries induce hypermetabolic and hypercatabolic responses that increase nutritional requirements. This retrospective cohort study aimed to evaluate the association between the adequacy of energy, protein, and zinc intake and the Sequential Organ Failure Assessment (SOFA) score and length of hospital stay in patients with major burns. Medical record data were obtained from patients treated at the Burn Unit of the Ngoerah General Hospital, Denpasar, between February 2025 and February 2026. Eligible patients were aged ≥17 years, had burns involving ≥20% of the total body surface area, received enteral nutrition, and were hospitalized for at least three days. Multivariable analyses were performed using negative binomial regression for SOFA scores and a generalized linear model with a gamma distribution and log link for the length of hospital stay. A total of 150 patients were included in the analysis. Energy, protein, and zinc adequacy were achieved by 31.3%, 41.3%, and 90.0% of the patients, respectively. None of the nutritional adequacy measures were independently associated with the length of hospital stay. Protein adequacy (adjusted IRR, 0.196; 95% CI, 0.038–0.999; P = 0.049) and zinc adequacy (adjusted IRR, 0.043; 95% CI, 0.017–0.109; P < .001) were independently associated with lower SOFA scores. In conclusion, adequate protein and zinc intakes were associated with lower SOFA scores; however, causality cannot be inferred from this retrospective study design. Prospective studies with temporally defined nutritional exposure are needed.
- Open Access
- 11 August 2026
- Published by Charles University in Prague, Karolinum Press in Acta Medica (Hradec Kralove, Czech Republic)
- Vol. 69 (2) , 55-64
The Emerging Role and Clinical Impact of Vitamin D Supplementation in Breast Cancer Patients Undergoing Chemotherapy: A Systematic Review
Introduction: Breast cancer is the most common cancer in women and is often diagnosed at an advanced stage. Chemotherapy plays a crucial role in disease control but is limited by toxicity and response variability. Vitamin D, with its biological functions and the high prevalence of deficiency in patients, has potential as an adjuvant therapy to improve treatment response and clinical outcomes. Objective: To integrate existing evidence on the role of vitamin D supplementation in breast cancer patients undergoing chemotherapy, focusing on its impact on treatment response and clinical outcomes. Methods: This systematic review followed PRISMA guidelines and included RCTs, cohort, and case-control studies evaluating vitamin D supplementation in adult women with breast cancer undergoing chemotherapy. A comprehensive search across five databases up to June 2025 was conducted, applying the pre-established PICOS criteria, with filtering, data extraction, and quality assessment performed. This systematic review has been prospectively registered in the PROSPERO database (CRD420251142938). Results: This systematic review identified six eligible studies involving breast cancer patients undergoing chemotherapy, with interventions ranging from low- to high-dose vitamin D, either alone or in combination with synbiotics. Vitamin D supplementation in breast cancer patients undergoing chemotherapy has been associated with improved clinical outcomes, including enhanced nutritional status, reduced inflammatory and cardiotoxic biomarkers, and increased pathological complete response (pCR) and disease-free survival (DFS). Conclusion: Vitamin D supplementation during chemotherapy shows potential benefits in breast cancer patients, but large-scale standardized trials with long-term follow-up are needed to confirm its impact on survival outcomes.
- 11 August 2026
- Published by Charles University in Prague, Karolinum Press in Acta Medica (Hradec Kralove, Czech Republic)
- Vol. 69 (2) , 55-64
Open AccessThe Emerging Role and Clinical Impact of Vitamin D Supplementation in Breast Cancer Patients Undergoing Chemotherapy: A Systematic Review
Introduction: Breast cancer is the most common cancer in women and is often diagnosed at an advanced stage. Chemotherapy plays a crucial role in disease control but is limited by toxicity and response variability. Vitamin D, with its biological functions and the high prevalence of deficiency in patients, has potential as an adjuvant therapy to improve treatment response and clinical outcomes. Objective: To integrate existing evidence on the role of vitamin D supplementation in breast cancer patients undergoing chemotherapy, focusing on its impact on treatment response and clinical outcomes. Methods: This systematic review followed PRISMA guidelines and included RCTs, cohort, and case-control studies evaluating vitamin D supplementation in adult women with breast cancer undergoing chemotherapy. A comprehensive search across five databases up to June 2025 was conducted, applying the pre-established PICOS criteria, with filtering, data extraction, and quality assessment performed. This systematic review has been prospectively registered in the PROSPERO database (CRD420251142938). Results: This systematic review identified six eligible studies involving breast cancer patients undergoing chemotherapy, with interventions ranging from low- to high-dose vitamin D, either alone or in combination with synbiotics. Vitamin D supplementation in breast cancer patients undergoing chemotherapy has been associated with improved clinical outcomes, including enhanced nutritional status, reduced inflammatory and cardiotoxic biomarkers, and increased pathological complete response (pCR) and disease-free survival (DFS). Conclusion: Vitamin D supplementation during chemotherapy shows potential benefits in breast cancer patients, but large-scale standardized trials with long-term follow-up are needed to confirm its impact on survival outcomes.
- Open Access
- 17 April 2026
- Published by Universa Medicina in Universa Medicina
- Vol. 45 (1) , 125-134
Effect of astaxanthin supplementation on oxidative stress in adult women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
BackgroundPolycystic ovary syndrome (PCOS) can cause significant morbidity through fertility disorders and most often found in the productive age. Recent research suggests that oxidative stress plays an important role in the pathogenesis of PCOS. Astaxanthin (AST) has broad protective effects, particularly in the regulation of antioxidant and anti-inflammatory activity. The objective of this systematic review and meta-analysis was to evaluate the efficacy of AST supplementation on PCOS management. MethodsA systematic literature search was conducted in PubMed, Scopus, Science Direct, and Cochrane Library from January 2020 to March 2025. Randomized controlled trials (RCTs) assessing astaxanthin supplementation in adult women with PCOS were included. Outcomes of interest were malondialdehyde (MDA), superoxide dismutase (SOD), and total antioxidant capacity (TAC). Data were analyzed using Review Manager (RevMan) version 5.4.1. Pooled effects were calculated as mean differences (MDs) with 95% confidence intervals (CIs). ResultsFour RCTs involving 194 participants were included. Astaxanthin supplementation significantly reduced MDA levels (MD −0.670; 95% CI −1.070 to −0.270; p = 0.001; I² = 93%) and significantly increased TAC levels (MD 0.030; 95% CI 0.000 to 0.060; p = 0.030; I² = 76%). No significant effect was observed on SOD levels (MD 0.025; 95% CI −0.850 to 1.350; p = 0.660; I² = 57%). The overall risk of bias across included studies was low. ConclusionThis systematic review shows that AST supplementation significantly reduced lipid peroxidation in women with PCOS. These findings suggest that AST may serve as potential adjuvant antioxidant therapy in PCOS management.
- 17 April 2026
- Published by Universa Medicina in Universa Medicina
- Vol. 45 (1) , 125-134
Open AccessEffect of astaxanthin supplementation on oxidative stress in adult women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
BackgroundPolycystic ovary syndrome (PCOS) can cause significant morbidity through fertility disorders and most often found in the productive age. Recent research suggests that oxidative stress plays an important role in the pathogenesis of PCOS. Astaxanthin (AST) has broad protective effects, particularly in the regulation of antioxidant and anti-inflammatory activity. The objective of this systematic review and meta-analysis was to evaluate the efficacy of AST supplementation on PCOS management. MethodsA systematic literature search was conducted in PubMed, Scopus, Science Direct, and Cochrane Library from January 2020 to March 2025. Randomized controlled trials (RCTs) assessing astaxanthin supplementation in adult women with PCOS were included. Outcomes of interest were malondialdehyde (MDA), superoxide dismutase (SOD), and total antioxidant capacity (TAC). Data were analyzed using Review Manager (RevMan) version 5.4.1. Pooled effects were calculated as mean differences (MDs) with 95% confidence intervals (CIs). ResultsFour RCTs involving 194 participants were included. Astaxanthin supplementation significantly reduced MDA levels (MD −0.670; 95% CI −1.070 to −0.270; p = 0.001; I² = 93%) and significantly increased TAC levels (MD 0.030; 95% CI 0.000 to 0.060; p = 0.030; I² = 76%). No significant effect was observed on SOD levels (MD 0.025; 95% CI −0.850 to 1.350; p = 0.660; I² = 57%). The overall risk of bias across included studies was low. ConclusionThis systematic review shows that AST supplementation significantly reduced lipid peroxidation in women with PCOS. These findings suggest that AST may serve as potential adjuvant antioxidant therapy in PCOS management.
- Open Access
- 8 April 2025
- Published by Universitas Udayana in E-Jurnal Medika Udayana
- Vol. 14 (4) , 78-84
THE RELATIONSHIP BETWEEN THE DURATION OF HEMODIALYSIS AND BODY MASS INDEX IN CHRONIC KIDNEY DISEASE PATIENTS AT SANJIWANI HOSPITAL
Chronic kidney disease (CKD) occurs when kidney function declines, as indicated by a glomerular filtration rate (GFR) below 60 mL/min/1.73 m² for 3 months or more. Hemodialysis is used to replace the lost kidney function. However, long-term hemodialysis can worsen the nutritional status of patients. Body mass index (BMI) is a good non-invasive indicator for assessing nutritional status. The purpose of this study is to determine the relationship between the duration of hemodialysis and BMI in CKD patients at Sanjiwani Hospital. This analytical observational study used a cross-sectional approach involving 95 CKD patients undergoing hemodialysis at Sanjiwani Hospital who met the inclusion and exclusion criteria. The relationship between the duration of hemodialysis and BMI was analyzed using the Spearman correlation test. The study subjects were predominantly male (63.2%), with a median age of 50 years (range: 21-63 years). The median duration of hemodialysis was 3 years (range: 1-17 years). The mean BMI was 24.15 ± 4.56 kg/m². The analysis showed a significant relationship between the duration of hemodialysis and BMI (r = -0.211, p = 0.04). This study concludes that there is a weak but significant negative correlation between the duration of hemodialysis and BMI, with a tendency for longer hemodialysis duration to be associated with a decrease in BMI.
- 8 April 2025
- Published by Universitas Udayana in E-Jurnal Medika Udayana
- Vol. 14 (4) , 78-84
Open AccessTHE RELATIONSHIP BETWEEN THE DURATION OF HEMODIALYSIS AND BODY MASS INDEX IN CHRONIC KIDNEY DISEASE PATIENTS AT SANJIWANI HOSPITAL
Chronic kidney disease (CKD) occurs when kidney function declines, as indicated by a glomerular filtration rate (GFR) below 60 mL/min/1.73 m² for 3 months or more. Hemodialysis is used to replace the lost kidney function. However, long-term hemodialysis can worsen the nutritional status of patients. Body mass index (BMI) is a good non-invasive indicator for assessing nutritional status. The purpose of this study is to determine the relationship between the duration of hemodialysis and BMI in CKD patients at Sanjiwani Hospital. This analytical observational study used a cross-sectional approach involving 95 CKD patients undergoing hemodialysis at Sanjiwani Hospital who met the inclusion and exclusion criteria. The relationship between the duration of hemodialysis and BMI was analyzed using the Spearman correlation test. The study subjects were predominantly male (63.2%), with a median age of 50 years (range: 21-63 years). The median duration of hemodialysis was 3 years (range: 1-17 years). The mean BMI was 24.15 ± 4.56 kg/m². The analysis showed a significant relationship between the duration of hemodialysis and BMI (r = -0.211, p = 0.04). This study concludes that there is a weak but significant negative correlation between the duration of hemodialysis and BMI, with a tendency for longer hemodialysis duration to be associated with a decrease in BMI.
- Open Access
- 8 April 2025
- Published by Universitas Udayana in E-Jurnal Medika Udayana
- Vol. 14 (4) , 107-113
CORRELATION OF HBA1C WITH NEUTROPHIL-LYMPHOCYTE RATIO AND MONOCYTE-LYMPHOCYTE RATIO AS MARKERS OF INFLAMMATION IN TYPE 2 DIABETES MELLITUS PATIENTS AT SANJIWANI HOSPITAL FROM 2021 TO 2023
Chronic inflammation in type 2 diabetes mellitus (T2DM) is the main link between hyperglycemia and immune system dysfunction. Chronic inflammation that cannot be controlled can increase the risk of complications. This inflammatory state is caused by growing glycemic levels as assessed by HbA1c examination. Previous studies have shown that the neutrophil-lymphocyte ratio (NLR) and monocyte-lymphocyte ratio (MLR) are inflammatory markers that can indicate immune system dysfunction. This study aims to determine the correlation of HbA1c with NLR and MLR as markers of inflammation in T2DM patients at Sanjiwani Regional Hospital for the 2021–2023 period. This research utilized a cross-sectional method. The study sample size was 73 T2DM patients who met the research criteria. The correlation of HbA1c with NLR and MLR was analyzed using the Spearman correlation test. Of the 73 research samples, it was found that 43 people (58.9%) were men, and 30 people (41.1%) were women, with an average ± SD age of 57.88 ± 9.98 years. The median HbA1c value was 8.80% (6.5%–14.5%), the median NLR value was 2.64 (0.89–6.78), and the median MLR value was 0.22 (0.02–0.57). The results of Spearman's correlation analysis between HbA1c and NLR showed no significant correlation (r = 0.195, p = 0.098), and the correlation between HbA1c and MLR was also not significant (r = 0.146, p = 0.217). So, it can be concluded that there is no significant correlation between HbA1c with NLR and MLR. Keywords: type 2 diabetes mellitus, chronic inflammation, HbA1c, neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio
- 8 April 2025
- Published by Universitas Udayana in E-Jurnal Medika Udayana
- Vol. 14 (4) , 107-113
Open AccessCORRELATION OF HBA1C WITH NEUTROPHIL-LYMPHOCYTE RATIO AND MONOCYTE-LYMPHOCYTE RATIO AS MARKERS OF INFLAMMATION IN TYPE 2 DIABETES MELLITUS PATIENTS AT SANJIWANI HOSPITAL FROM 2021 TO 2023
Chronic inflammation in type 2 diabetes mellitus (T2DM) is the main link between hyperglycemia and immune system dysfunction. Chronic inflammation that cannot be controlled can increase the risk of complications. This inflammatory state is caused by growing glycemic levels as assessed by HbA1c examination. Previous studies have shown that the neutrophil-lymphocyte ratio (NLR) and monocyte-lymphocyte ratio (MLR) are inflammatory markers that can indicate immune system dysfunction. This study aims to determine the correlation of HbA1c with NLR and MLR as markers of inflammation in T2DM patients at Sanjiwani Regional Hospital for the 2021–2023 period. This research utilized a cross-sectional method. The study sample size was 73 T2DM patients who met the research criteria. The correlation of HbA1c with NLR and MLR was analyzed using the Spearman correlation test. Of the 73 research samples, it was found that 43 people (58.9%) were men, and 30 people (41.1%) were women, with an average ± SD age of 57.88 ± 9.98 years. The median HbA1c value was 8.80% (6.5%–14.5%), the median NLR value was 2.64 (0.89–6.78), and the median MLR value was 0.22 (0.02–0.57). The results of Spearman's correlation analysis between HbA1c and NLR showed no significant correlation (r = 0.195, p = 0.098), and the correlation between HbA1c and MLR was also not significant (r = 0.146, p = 0.217). So, it can be concluded that there is no significant correlation between HbA1c with NLR and MLR. Keywords: type 2 diabetes mellitus, chronic inflammation, HbA1c, neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio
- 4 January 2024
- Published by DiscoverSys, Inc. in Intisari Sains Medis
- Vol. 15 (1) , 62-78
Hubungan Polimorfisme Gen Matriks Metalloproteinase-9 (MMP-9) rs3918242 (C-1562T) dengan Metastasis Kanker Payudara
Introduction: Breast cancer, constituting 16.6% of all cancer cases in Indonesia, involves uncontrolled cell growth in the breast epithelium. Diagnostic delays contribute to decreased survival rates. Despite screening efforts, treatment delays persist, necessitating effective early detection markers. The MMP-9 rs3918242 gene polymorphism's link to breast cancer risk remains inconclusive. This study investigates the association between MMP-9 gene polymorphism rs3918242 (C-1562T) and breast cancer metastasis, aiming to enhance understanding and early detection strategies. Method: This analytical descriptive research with a cross-sectional design was carried out for 6 months at the Biochemistry Laboratory, Faculty of Medicine and Integrated Biomedical Laboratory, Udayana University. The samples for this research were 46 stored biological materials from venous blood samples. Identification of the MMP-9 rs3918242 polymorphism was carried out by DNA isolation, PCR, and sequencing. Data were analyzed using software tools in the form of univariate and bivariate analysis to determine the relationship between the MMP-9 rs3918242 gene polymorphism and breast cancer metastasis. Results: In 46 research samples, metastatic cases were found in 18 samples (37%) and non-metastatic cases in 29 samples (63%). The distribution of polymorphisms was found to be dominant in the CC (60.8%), CT (19.6%) and TT (19.6%) genotypes. There is a significant relationship between the MMP-9 gene polymorphism rs3918242 CT + TT genotype and breast cancer metastasis with a p-value of 0.036 (<0.05) and a prevalence ratio of 2.132 (95% CI: 1.047-4.343). Conclusion: There is a significant relationship between the MMP-9 rs3918242 gene polymorphism and breast cancer metastasis. Pendahuluan: Kanker payudara merupakan pertumbuhan sel secara abnormal dan tidak terkontrol pada epitel payudara. Prevalensi kanker payudara mencapai 16,6% dari seluruh jenis kanker di Indonesia. Keterlambatan diagnosis sampai saat ini masih menjadi permasalahan dalam penatalaksanaan kanker payudara sehingga survival rate pasien menurun. Upaya screening dan diagnostik sudah dilakukan, namun keterlambatan penanganan masih tinggi, sehingga diperlukan marker yang efektif sebagai deteksi dini risiko kanker payudara. Beberapa studi telah mengkaji mengenai hubungan polimorfisme gen MMP-9 rs3918242 dengan risiko kanker payudara namun hasil yang didapatkan masih bervariasi. Tujuan dari penelitian ini adalah untuk mengetahui hubungan antara polimorfisme gen MMP-9 rs3918242 (C-1562T) dengan metastasis pada kanker payudara. Metode: Penelitian deskriptif analitik dengan desain potong lintang ini dilaksanakan selama 6 bulan berloaksi di Laboratorium Biokimia Fakultas Kedokteran dan Laboratorium Biomedik Terpadu, Universitas Udayana. Sampel penelitian ini adalah bahan biologi tersimpan sampel darah vena berjumlah 46. Identifikasi polimorfisme MMP-9 rs3918242 dilakukan isolasi DNA, PCR dan sequensing. Data dianalisis menggunakan piranti perangkat lunak berupa analisis univariat dan bivariat untuk mengetahui hubungan polimorfisme gen MMP-9 rs3918242 dengan metastasis kanker payudara. Hasil: Pada 46 sampel penelitian ditemukan kasus metastasis sebanyak 18 sampel (37%) dan non-metastasis sebanyak 29 sampel (63%). Distribusi polimorfisme ditemukan dominan pada genotipe CC (60,8%), CT (19,6%) dan TT (19,6%). Terdapat hubungan signifikan antara polimorfisme gen MMP-9 rs3918242 genotipe CT + TT terhadap metastasis kanker payudara dengan nilai p 0.036 (<0.05) dan prevalence ratio sebesar 2.132 (95% CI: 1.047-4.343). Kesimpulan: Terdapat hubungan yang signifikan dan bermakna antara polimorfisme gen MMP-9 rs3918242 dengan metastasis kanker payudara.
- 4 January 2024
- Published by DiscoverSys, Inc. in Intisari Sains Medis
- Vol. 15 (1) , 62-78
Hubungan Polimorfisme Gen Matriks Metalloproteinase-9 (MMP-9) rs3918242 (C-1562T) dengan Metastasis Kanker Payudara
Introduction: Breast cancer, constituting 16.6% of all cancer cases in Indonesia, involves uncontrolled cell growth in the breast epithelium. Diagnostic delays contribute to decreased survival rates. Despite screening efforts, treatment delays persist, necessitating effective early detection markers. The MMP-9 rs3918242 gene polymorphism's link to breast cancer risk remains inconclusive. This study investigates the association between MMP-9 gene polymorphism rs3918242 (C-1562T) and breast cancer metastasis, aiming to enhance understanding and early detection strategies. Method: This analytical descriptive research with a cross-sectional design was carried out for 6 months at the Biochemistry Laboratory, Faculty of Medicine and Integrated Biomedical Laboratory, Udayana University. The samples for this research were 46 stored biological materials from venous blood samples. Identification of the MMP-9 rs3918242 polymorphism was carried out by DNA isolation, PCR, and sequencing. Data were analyzed using software tools in the form of univariate and bivariate analysis to determine the relationship between the MMP-9 rs3918242 gene polymorphism and breast cancer metastasis. Results: In 46 research samples, metastatic cases were found in 18 samples (37%) and non-metastatic cases in 29 samples (63%). The distribution of polymorphisms was found to be dominant in the CC (60.8%), CT (19.6%) and TT (19.6%) genotypes. There is a significant relationship between the MMP-9 gene polymorphism rs3918242 CT + TT genotype and breast cancer metastasis with a p-value of 0.036 (<0.05) and a prevalence ratio of 2.132 (95% CI: 1.047-4.343). Conclusion: There is a significant relationship between the MMP-9 rs3918242 gene polymorphism and breast cancer metastasis. Pendahuluan: Kanker payudara merupakan pertumbuhan sel secara abnormal dan tidak terkontrol pada epitel payudara. Prevalensi kanker payudara mencapai 16,6% dari seluruh jenis kanker di Indonesia. Keterlambatan diagnosis sampai saat ini masih menjadi permasalahan dalam penatalaksanaan kanker payudara sehingga survival rate pasien menurun. Upaya screening dan diagnostik sudah dilakukan, namun keterlambatan penanganan masih tinggi, sehingga diperlukan marker yang efektif sebagai deteksi dini risiko kanker payudara. Beberapa studi telah mengkaji mengenai hubungan polimorfisme gen MMP-9 rs3918242 dengan risiko kanker payudara namun hasil yang didapatkan masih bervariasi. Tujuan dari penelitian ini adalah untuk mengetahui hubungan antara polimorfisme gen MMP-9 rs3918242 (C-1562T) dengan metastasis pada kanker payudara. Metode: Penelitian deskriptif analitik dengan desain potong lintang ini dilaksanakan selama 6 bulan berloaksi di Laboratorium Biokimia Fakultas Kedokteran dan Laboratorium Biomedik Terpadu, Universitas Udayana. Sampel penelitian ini adalah bahan biologi tersimpan sampel darah vena berjumlah 46. Identifikasi polimorfisme MMP-9 rs3918242 dilakukan isolasi DNA, PCR dan sequensing. Data dianalisis menggunakan piranti perangkat lunak berupa analisis univariat dan bivariat untuk mengetahui hubungan polimorfisme gen MMP-9 rs3918242 dengan metastasis kanker payudara. Hasil: Pada 46 sampel penelitian ditemukan kasus metastasis sebanyak 18 sampel (37%) dan non-metastasis sebanyak 29 sampel (63%). Distribusi polimorfisme ditemukan dominan pada genotipe CC (60,8%), CT (19,6%) dan TT (19,6%). Terdapat hubungan signifikan antara polimorfisme gen MMP-9 rs3918242 genotipe CT + TT terhadap metastasis kanker payudara dengan nilai p 0.036 (<0.05) dan prevalence ratio sebesar 2.132 (95% CI: 1.047-4.343). Kesimpulan: Terdapat hubungan yang signifikan dan bermakna antara polimorfisme gen MMP-9 rs3918242 dengan metastasis kanker payudara.